Fig. 7
From: Therapeutic efficacy of sorafenib and plant-derived phytochemicals in human colorectal cancer cells
Cell cycle of human CRC cell lines treated with Sora, Que or Kmf and a combination of all treatments. A The SW1116 human CRC cell line was UT, or treated with Sora (5 µM), Que (200 µM), Que (400 µM), and simultaneous combinations of Sora and Que (5 + 200 µM or 5 + 400 µM) for 72 h. B The SW837 human CRC cell line was UT, or treated with Sora (5 µM), Kmf (200 µM), Kmf (400 µM), and sequential treatments of Sora and Kmf (5 + 200 µM or 5 + 400 µM) for 72 h. Sora, sorafenib; Que, quercetin; Kmf, kaempherol; UT, untreated; CRC, colorectal cancer